Showing results (1-10 of 276) with videos related to
Sort By:
Pageof 28
Journal of Clinical Epidemiology|August 23, 2011
McMaster Premium LiteratUre Service (PLUS) performed well for identifying new studies for updated Cochrane reviewsBrian J Hemens, R Brian HaynesHematology. American Society of Hematology. Education Program|December 10, 2017
Using pharmacokinetics to individualize hemophilia therapyAlfonso IorioSeminars in Thrombosis and Hemostasis|August 14, 2015
Individualizing factor replacement therapy in severe hemophiliaManuel D Carcao, Alfonso IorioCurrent Treatment Options in Cardiovascular Medicine|January 25, 2013
Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approachMaura Marcucci, Alfonso Iorio, James DouketisBlood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike MakrisPathophysiology of Haemostasis and Thrombosis|December 8, 2004
Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three monthsSerenella Conti, Francesco Guercini, Alfonso IorioHaemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Emicizumab state-of-the-art updateJohnny Mahlangu, Alfonso Iorio, Gili KenetBritish Journal of Haematology|April 8, 2017
Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn moreAlfonso Iorio, Kathelijn Fischer, Michael MakrisResearch and Practice in Thrombosis and Haemostasis|March 18, 2021
Extended half-life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two productsJerome Teitel, Michelle Sholzberg, Alfonso IorioThe American Journal of Gastroenterology|June 11, 2009
Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virusLise Lotte Gluud, Emanuela Marchesini, Alfonso IorioPageof 28